文献速递流行病学与生物统计

基于决策阈值的Meta分析不一致性定量评估:两个新指标

Quantitative assessment of inconsistency in meta-analysis using decision thresholds with two new indices.
PubMed 文献 · J Clin Epidemiol · 2025-02-13

本研究开发了基于决策阈值(DT)的两个新指标——决策不一致性(DI)和跨研究不一致性(ASI),用于定量评估Meta分析中的不一致性。DI和ASI基于后验样本研究效应量在DT定义的解读类别间的分布,先构建贝叶斯版本,后扩展至频率学框架。DI≥50%和ASI≥25%提示重要不一致性,并提供R包(metainc)和网页工具支持计算。

要点

  • 开发了基于决策阈值的决策不一致性(DI)和跨研究不一致性(ASI)两个新指标。
  • DI反映效应量在解读类别间的总体不一致性,ASI量化研究间基于绝对效应的差异。
  • DI≥50%和ASI≥25%提示重要不一致性,并提供R包和网页工具支持计算。

核心结论

  • DI和ASI有助于定量评估不一致性,尤其当决策阈值在证据合成和健康决策中日益受到认可时。

研究设计与样本

  • 方法学研究,开发基于决策阈值的两个不一致性指标(DI和ASI),先构建贝叶斯版本,后扩展至频率学框架。

主要发现

  • DI反映效应量在解读类别间的总体不一致性,ASI量化研究间基于绝对效应的差异。
  • DI≥50%和ASI≥25%提示重要不一致性。

关键数值与推荐

  • DI≥50%和ASI≥25%提示重要不一致性。

临床怎么用

  • 提供R包(metainc)和网页工具(https://metainc.med.up.pt/)支持DI和ASI的计算,包括敏感性分析评估不一致性潜在不确定性的影响。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: In evidence synthesis, inconsistency is typically assessed visually and with the I2 and the Q statistics. However, these measures have important limitations (i) if there are few primary studies of small sample sizes or (ii) if there are multiple studies with precise estimates. In addition, with the increasing use of decision thresholds (DT), for example in Grading of Recommendations Assessment, Development and Evaluation evidence to decision (EtD) frameworks, inconsistency judgments can be anchored around DTs. In this article, we developed quantitative measures to assess inconsistency based on DTs. STUDY DESIGN AND SETTING: We developed two measures to quantify inconsistency based on DTs - the decision inconsistency (DI) and the across-studies inconsistency (ASI) indices. The DI and the ASI are based on the distribution of the posterior samples studies' effect sizes (ES) across interpretation categories defined by DTs. We developed these indices for the Bayesian context, followed by a frequentist extension. RESULTS: The DI informs on the overall inconsistency of ESs across interpretation categories, while the ASI quantifies how different studies are compared to each other (in relation to interpretation categories) based on absolute effects. A DI ≥ 50% and an ASI ≥ 25% are suggestive of important inconsistency. We provide an R package (metainc) and a web tool (https://metainc.med.up.pt/) to support the computation of the DI and ASI, including in the context of sensitivity analyses assessing the impact of potential uncertainty in inconsistency. CONCLUSION: The DI and the ASI can contribute to quantitatively assess inconsistency, particularly as DTs are gaining recognition in evidence synthesis and health decision-making.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Sousa-Pinto B, Neumann I, Vieira RJ, et al. Quantitative assessment of inconsistency in meta-analysis using decision thresholds with two new indices. J Clin Epidemiol. 2025. PMID: 39955079. doi:10.1016/j.jclinepi.2025.111725

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。